, APAC
Photo from Envato

Atopic dermatitis market to reach $16.7b by 2030 across seven major markets

Pharmaceutical firms are urged to capitalise on current trends in AD trials.

The atopic dermatitis (AD) market is projected to reach $16.7b by 2030 across the seven major markets (7MM), notably the US, France, Germany, Italy, Spain, the UK, and Japan, according to GlobalData.

The report revealed that as of 2020, approximately 781 million patients within the 7MM were reported to have AD, with this figure expected to grow.

The existing treatment paradigm primarily includes topical corticosteroids, moisturisers, antihistamines, and recently approved inhibitors. However, these therapies often provide temporary relief and may come with potential side effects.

Filippos Maniatis, a healthcare analyst at GlobalData, noted that pharmaceutical companies should capitalise on current trends in AD trials by investing in research and development (R&D), establishing collaborations, and adopting patient-focused strategies.

The analyst further cited existing partnerships in the sector, notably the collaboration between Regeneron and Sanofi, which led to the development of Dupixent, a treatment for moderate to severe AD. 

“The anticipated sales of Dupixent for AD are projected to reach $6.2b in 2030, highlighting the significant rewards and substantial potential in this rapidly evolving market,” Maniatis added.

 

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.